The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia

  1. Santamaría, C.
  2. Chillón, M.C.
  3. García-Sanz, R.
  4. Balanzategui, A.
  5. Sarasquete, M.E.
  6. Alcoceba, M.
  7. Ramos, F.
  8. Bernal, T.
  9. Queizán, J.A.
  10. Peñarrubia, M.J.
  11. Giraldo, P.
  12. San Miguel, J.F.
  13. Gonzalez, M.
Aldizkaria:
Haematologica

ISSN: 0390-6078

Argitalpen urtea: 2008

Alea: 93

Zenbakia: 12

Orrialdeak: 1797-1805

Mota: Artikulua

DOI: 10.3324/HAEMATOL.13214 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus